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Introduction
In the domain of tissue engineering, the repair of skeletal defects
is an immediate clinical need as impaired fracture healing or non-
union bone defects often result in a functional disability for which
there is no effective therapy [1].Conventional tissue engineering
strategies utilize combination of biodegradable porous scaffolds
and bioactive molecules such as growth factors to mimic natural
processes of healing [2]. However, such approaches often
produce unpredictable results, probably due to the short
biological half life of bioactive molecules and lack of long term
stability and tissue specificity [3]. The aim of this work is to
prepare chitosan-gelatin (CH/G) scaffolds embedded with PLGA
nanoparticles for the purpose of localized growth factor delivery
at a pre-determined rate and to improve the therapeutic efficiency
of scaffolds by mimicking the endogenous release of bioactive
substance(s).
Results and discussion
The use of CH/G blends as scaffolding materials may affect cell adhesion, scaffold bioactivity, tissue remodelling
process and the quality of the regenerated tissue. Genipin-crosslinking stabilized the chitosan-gelatin blends in
water solution and pre-freezing at -20°C warranted the uniform gel formation. Freezing resulted in the formation of
ice crystals inside polymer solution which act as porogens during freeze drying process that resulted in a porous
(160-200 microns) 3D polymer scaffold (Fig.3). PLGA nanoparticles formed ere spherical in shape and displayed
a smooth surface with an average size below 200 nm (Fig.4). PLGA nanoparticles were uniformly distributed and
located in the walls or void spaces of the CH/G scaffold (irrespective to the amount of nanoparticles used) as
witnessed in SEM image (Fig.5).
Materials and Methods
Chitosan (CH) and Type A gelatin (G) from porcine skin were
supplied from Sigma-Aldrich.
Figure 2. Schematic representation of formation of PLGA
nanoparticles (Ref. 5)
Conclusions
Scaffolds incorporated with PLGA nanoparticles displayed lower swelling than CH/G scaffolds without nanoparticles. Incorporation of the hydrophobic PLGA nanoparticles in the
relatively hydrophilic CH/G scaffold modulated the porous structure and tensile strength of the scaffold. Studies are in progress to evaluate the release kinetics of particles embedded
into CH/G scoffolds. GP crosslinked CH/G blends embedded with PLGA nanoparticles containing suitable growth factor can be used in the form of porous scaffolds, to enhance bone
regeneration.
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Nanoparticles-embedded scaffolds were constructed by
dispersing various amounts of PLGA nanoparticles (PLGA
NP) into 1 ml of CH/G blend solution before the pre-frozen
and freezedrying steps, which were described above.
Scaffolds were characterised for their stability (swelling and
dissolution tests), morphology (scanning electron microscopy,
SEM).
LOGO CONGRESSO
Figure 1. Fabrication of porous CH-G scaffolds. (Ref. 4)
Figure 5. Porous CH-G scaffolds
embedded with PLGA nanoparticles.
Figure 3. Porous CH-G scaffolds
Figure 4. PLGA nanoparticles.
Scaffolds with PLGA nanoparticles displayed heterogeneous porous structure (Fig.5) which could be attributed to the
fusion of two or three adjacent pores by the rupture of common pore walls. This might be due to the steric effect of the
embedded nanoparticles or to the strong water repelling force exerted by the hydrophobic nanoparticles. Furthermore,
scaffolds containing PLGA nanoparticles displayed lower % swelling and higher mechanical properties than the ones
without particles (Fig.6&7). Weight loss in water due to CH/G release ranged between 29 to 49 % for scaffolds after 10
days immersion in Phosphate buffered saline(PBS) (Tab. 1).
Group
Initial Wt.  mg
(mean±S.D.)
Final wt.  mg
(mean±S.D.)
% wt 
loss
CH-G scaffolds 250.5±12.1 127.3±13.8
49.16 
±0.63
CH-G with 5 mg/ml 
PLGA NP
258.4±20.6 163.7±31.8
36.6 
±6.43
CH-G with 10 
mg/ml PLGA NP
235.9±16.24 126.6±28.6
46.63 
±18.43
CH-G with 20 
mg/ml PLGA NP
240.1±9.1 169.2±11.1
29.50 
±7.10
Table 1. Dissolution of scaffolds after 10 days of immersion in
PBS.
Add Genipin 2.5% w/w w.r.t 
gelatin/chitosan amount.
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Figure 6. %Swelling of scaffolds in PBS. Reported values are
the averages and bars indicate the S.D. (n=3)
Figure 7. Compressive Young’s modulus for Scaffolds. Reported
values are the averages and bars indicate the S.D. (n=3)
Figure 8. Supernatant pH changes during the dissolution of scaffolds
as a function of time at 37°C. Reported values are the averages (n=3)
The measured pH of the incubation media indicated acidic conditions after immersion of the obtained scaffolds in PBS,
which could be attributed to the degradation of chitosan. In case of control samples the maximum acidic condition
occurred after first week then pH raised closure to initial pH. On the other hand, samples containing PLGA particles
displayed more acidic conditions probably due to the degradation of PLGA particles. (Fig. 8)
pH changes in incubation medium
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